SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Psoriasis/Chronic Inflammation
An SI Board Since February 2001
Posts SubjectMarks Bans
631 42 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
431AGI-1067 is bis-(butane acid derivatization) of the Probucol, known fenolic antiMiljenko Zuanic-6/17/2003
430Or both ? United States Patent 6,475,987 Shu November 5, 2002 ------------nigel bates-6/17/2003
429<i>BAFF; also known as TALL-1, THANK, BlyS, and zTNF4</i> Gotta havnigel bates-6/17/2003
428>> BAFF-R was first identified by Biogen << Now come on, it can'scaram(o)uche-6/17/2003
427BGEN / DNA / BR3 (BAFF-R) protein SOUTH SAN FRANCISCO, Calif., and CAMBRIDGE, Mnigel bates-6/17/2003
426>> are you following AGI 1067 << Sort of, very loosely. I've fscaram(o)uche-6/17/2003
425Richard, are you following AGI 1067, from AGIX?///Just looked on SI, I see you aSavant-6/16/2003
424freebie from Nature.... a bit more information than one wants, but..... goscaram(o)uche-6/15/2003
423Thanks Rick. I guess, we will have an answer within a week or two. That is at lIcebrg-6/14/2003
422>> Now we need the help from Rick << Finally getting around to catcscaram(o)uche-6/14/2003
421Enzo Biochem Initiates Phase II Study of Crohn's Disease Treatment Monday JuIcebrg-6/9/2003
420Icos, Biogen and LFA-1. I think one of the interesting aspects here is that BioIcebrg-6/6/2003
419ICOS Regains Full Rights to LFA-1 Program Friday June 6, 7:01 am ET Moves ForwarIcebrg-6/6/2003
418Highlights From Digestive Disease Week: An Expert Interview With Lawrence R. SchIcebrg-6/5/2003
417Any of the Chrohn's watchers know what's going on with ABT-874?keokalani'nui-6/4/2003
416Oral Pimecrolimus Peter S has posted some interesting data on oral PimecrolimusIcebrg-5/26/2003
415Tom >>Very anecdotal - and therefore useless - Asacol in my experience isIcebrg-5/22/2003
4145-aminosalicylate is Asacol, I believe. Very anecdotal - and therefore uselesstom pope-5/21/2003
413Isotechnika - ISA.TO I have joined the Isotechnika camp. This is indeed very inIcebrg-5/21/2003
412IBD - inflammatory bowel disease. There are a number of different treatment opIcebrg-5/21/2003
411[SANG -- UC & Crohn's -- RDP58] Better response & remission rates, tuck-5/21/2003
410>>Something strange is going on???>> [Thinking a little bit about tIcebrg-5/16/2003
409>>Something strange is going on???>> Indeed. Crohn's seems to bIcebrg-5/16/2003
408<<[This is the MLN02 Crohn's abstract. It appears that they might haveMiljenko Zuanic-5/16/2003
407Efficacy and Safety of a Humanized &#945;4&#946;7 Antibody in Active CroIcebrg-5/15/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News